Search

Bruce McHarrie

Bruce McHarrie has been in the biotechnology industry for over 15 years. Mr McHarrie joined the Institute in 1999 after returning to Perth from the United Kingdom where he was Assistant Director in the Bioscience Unit at Rothschild Asset Management. The Bioscience Unit focused on investing in biotechnology and healthcare companies from the early start-up stage through to the publicly listed stage. In this capacity Mr McHarrie was invited to join the board of a number of United Kingdom based biotechnology companies. Prior to joining Rothschild Asset Management, Mr McHarrie was with Coopers and Lybrand in London servicing a client base primarily in the financial services industry.
Bio last updated 14 Nov 2018

Access to our data for Bruce McHarrie is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Bruce McHarrie is linked to 3 organisations which are included in 2 lists - Business News 30 and Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
152ndAusCann Group Holdings33%50%
417thPhylogica-11%13%
717thNeurotech International-56%0%
799thTech Mpire-72%-19%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Roles

2016
Non-Executive Director
Year started and most recent title

Revenue

209th↓Tech Mpire$73k
210th↓Neurotech International$67k
211th↓AusCann Group Holdings$54k
212th↓Activistic$49k
213th↓Phylogica$48k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer